Impact of histological variants on clinical outcomes of patients with upper urinary tract urothelial carcinoma
Standard
Impact of histological variants on clinical outcomes of patients with upper urinary tract urothelial carcinoma. / Rink, Michael; Robinson, Brian D; Green, David A; Cha, Eugene K; Hansen, Jens; Comploj, Evi; Margulis, Vitaly; Raman, Jay D; Ng, Casey K; Remzi, Mesut; Bensalah, Karim; Kabbani, Wareef; Haitel, Andrea; Rioux-Leclercq, Nathalie; Guo, Charles C; Chun, Felix K; Kikuchi, Eiji; Kassouf, Wassim; Sircar, Kanishka; Sun, Maxine; Sonpavde, Guru; Lotan, Yair; Pycha, Armin; Karakiewicz, Pierre I; Scherr, Douglas S; Shariat, Shahrokh F.
in: J UROLOGY, Jahrgang 188, Nr. 2, 2, 08.2012, S. 398-404.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Impact of histological variants on clinical outcomes of patients with upper urinary tract urothelial carcinoma
AU - Rink, Michael
AU - Robinson, Brian D
AU - Green, David A
AU - Cha, Eugene K
AU - Hansen, Jens
AU - Comploj, Evi
AU - Margulis, Vitaly
AU - Raman, Jay D
AU - Ng, Casey K
AU - Remzi, Mesut
AU - Bensalah, Karim
AU - Kabbani, Wareef
AU - Haitel, Andrea
AU - Rioux-Leclercq, Nathalie
AU - Guo, Charles C
AU - Chun, Felix K
AU - Kikuchi, Eiji
AU - Kassouf, Wassim
AU - Sircar, Kanishka
AU - Sun, Maxine
AU - Sonpavde, Guru
AU - Lotan, Yair
AU - Pycha, Armin
AU - Karakiewicz, Pierre I
AU - Scherr, Douglas S
AU - Shariat, Shahrokh F
N1 - Copyright © 2012 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.
PY - 2012/8
Y1 - 2012/8
N2 - We investigated the clinical and prognostic impact of variant histologies on upper tract urothelial carcinoma outcomes after radical nephroureterectomy.
AB - We investigated the clinical and prognostic impact of variant histologies on upper tract urothelial carcinoma outcomes after radical nephroureterectomy.
KW - Adult
KW - Humans
KW - Male
KW - Aged
KW - Female
KW - Middle Aged
KW - Multivariate Analysis
KW - Prognosis
KW - Survival Analysis
KW - Follow-Up Studies
KW - Combined Modality Therapy
KW - Disease Progression
KW - Statistics as Topic
KW - Neoplasm Staging
KW - Chemotherapy, Adjuvant
KW - Kaplan-Meier Estimate
KW - Cell Transformation, Neoplastic/pathology
KW - Lymphatic Metastasis/pathology
KW - Neoplasm Invasiveness/pathology
KW - Carcinoma, Transitional Cell/drug therapy/mortality/pathology/surgery
KW - Kidney/pathology/surgery
KW - Kidney Neoplasms/drug therapy/mortality/pathology/surgery
KW - Nephrectomy
KW - Ureter/pathology/surgery
KW - Ureteral Neoplasms/drug therapy/mortality/pathology/surgery
KW - Adult
KW - Humans
KW - Male
KW - Aged
KW - Female
KW - Middle Aged
KW - Multivariate Analysis
KW - Prognosis
KW - Survival Analysis
KW - Follow-Up Studies
KW - Combined Modality Therapy
KW - Disease Progression
KW - Statistics as Topic
KW - Neoplasm Staging
KW - Chemotherapy, Adjuvant
KW - Kaplan-Meier Estimate
KW - Cell Transformation, Neoplastic/pathology
KW - Lymphatic Metastasis/pathology
KW - Neoplasm Invasiveness/pathology
KW - Carcinoma, Transitional Cell/drug therapy/mortality/pathology/surgery
KW - Kidney/pathology/surgery
KW - Kidney Neoplasms/drug therapy/mortality/pathology/surgery
KW - Nephrectomy
KW - Ureter/pathology/surgery
KW - Ureteral Neoplasms/drug therapy/mortality/pathology/surgery
U2 - 10.1016/j.juro.2012.04.009
DO - 10.1016/j.juro.2012.04.009
M3 - SCORING: Journal article
C2 - 22698626
VL - 188
SP - 398
EP - 404
JO - J UROLOGY
JF - J UROLOGY
SN - 0022-5347
IS - 2
M1 - 2
ER -